Holen Sie sich die Stockscreener-App
0.7152
0.32%
0.0023
Handel nachbörslich:
.72
0.0048
+0.67%
Schlusskurs vom Vortag:
$0.7129
Offen:
$0.73
24-Stunden-Volumen:
141.62K
Relative Volume:
0.47
Marktkapitalisierung:
$90.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-70.78M
KGV:
-1.2771
EPS:
-0.56
Netto-Cashflow:
$-61.27M
1W Leistung:
-9.19%
1M Leistung:
-8.48%
6M Leistung:
-58.42%
1J Leistung:
-68.77%
1-Tages-Spanne:
$0.7152
$0.7628
1-Wochen-Bereich:
$0.71
$0.764
52-Wochen-Spanne:
$0.66
$3.09
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Firmenname
Nautilus Biotechnology Inc
Sektor
Branche
Telefon
206-333-2001
Adresse
2701 EASTLAKE AVE EAST, SEATTLE
Vergleichen Sie NAUT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
0.7152 | 90.98M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-06-27 | Eingeleitet | Guggenheim | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2022-01-06 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Eingeleitet | Cowen | Outperform |
| 2021-08-04 | Eingeleitet | Goldman | Neutral |
| 2021-07-13 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Nautilus Biotechnology Inc Aktie (NAUT) Neueste Nachrichten
Heatmap analysis for Nautilus Biotechnology Inc. and competitorsTrade Volume Report & Fast Momentum Stock Entry Tips - Newser
Is Nautilus Biotechnology Inc. stock poised for growth2025 Top Gainers & Community Verified Trade Signals - Newser
Visual trend scoring systems applied to Nautilus Biotechnology Inc.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
How to integrate Nautilus Biotechnology Inc. into portfolio analysis toolsAI Entry Timing Prediction for Swing Traders - Newser
Can trapped investors hope for a rebound in Nautilus Biotechnology Inc.Breakout Watcher with Entry and Exit Alerts - Newser
Will Nautilus Biotechnology Inc. stock go up soonFree AI Screening for Swing Trade Picks - Newser
Quantitative breakdown of Nautilus Biotechnology Inc. recent moveAI Triggered Buy Zone Forecast System - Newser
Using R and stats models for Nautilus Biotechnology Inc. forecastingStrategy Playbook for Risk Controlled Trades - Newser
Using data filters to optimize entry into Nautilus Biotechnology Inc.Portfolio Allocation Strategy for Stability - Newser
Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionEquity Market Return Forecast Model Update - Newser
Momentum divergence signals in Nautilus Biotechnology Inc. chartReal Market Tracker with Price Action Tools - Newser
Combining price and volume data for Nautilus Biotechnology Inc.Free Entry Zone Strategy for Consistent Profit - Newser
Pattern recognition hints at Nautilus Biotechnology Inc. upsideSwing Trade Watchlist with Entry Zones - Newser
What earnings revisions data tells us about Nautilus Biotechnology Inc.Retirement Investment Outlook and Return Summary - Newser
What Fibonacci levels say about Nautilus Biotechnology Inc. reboundSafe Investment Ideas with Growth Upside - Newser
How Nautilus Biotechnology Inc. stock performs during market volatilityLong-Term Growth Trend Summary With Confidence - Newser
What makes Nautilus Biotechnology Inc. stock price move sharplyFree High Conviction Intraday Stock Signals - Newser
Nautilus Biotechnology Shares Rise 18% After Amazon Discloses Stake - AInvest
Signal strength of Nautilus Biotechnology Inc. stock in tech scannersLong-Term Growth Trend Summary With Confidence - Newser
Nautilus Biotechnology’s Q2 2025 Financial Highlights - TipRanks
Finanzdaten der Nautilus Biotechnology Inc-Aktie (NAUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Nautilus Biotechnology Inc-Aktie (NAUT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):